If you had looked at Intel on 1 January 2026, you would have seen a company caught between an ambitious chip roadmap and deep skepticism about execution. For Intel shareholders, the return from the start of the year was 129.9%, including dividends. The headlines now talk about AI partnerships, foundry orders and big capital raises, but early in the year the live debate was simpler. Would heavy spending and restructuring ever translate into sustainable, cash generative growth?
Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value.
The move put Intel in the middle of this trade. Scan 55 AI infrastructure stocks for other companies exposed to it.
The Two Intel Stories Investors Had To Weigh
The shares cost US$36.91 at the start of the period, and Intel investors were effectively choosing between two very different stories about what might come next.
On the bullish side, one July 2023 narrative put Fair Value at US$79, which was 114% above the start price. This view hinged on 10.0% revenue growth and a 22.0% profit margin assumption that relied on an ambitious chip roadmap and a PC recovery.
The more cautious December 2025 view pointed to Fair Value of US$25.18, which was 32% below the start price. This view assumed 3.5% revenue growth, a 7.8% margin and real execution risk around restructuring and AI execution.
What The Intel Evidence Actually Tested
Intel’s Q2 2026 report showed revenue of US$16.1b compared with US$12.9b a year earlier, which tilted the argument toward the bullish growth assumptions. The same filing reported a net loss of US$11.0b versus a US$2.9b loss in Q2 2025 and a net margin that moved further into negative territory. That profitability gap left the optimistic margin story unproven and meant the evidence cut both ways.
The lesson is simple. When a thesis hangs on both higher sales and healthier earnings, you need to track each separately. For another stock in a heavy investment phase, check whether rising revenue is matched by a less negative net margin rather than assuming top line momentum fixes the rest.
What Intel’s Run Now Asks You To Believe
Intel now trades at US$90.52, far above where the year started. The selected cautious Narrative still places its Fair Value below that level and leans on concerns that are more about execution than ambition.
The thesis stresses Intel’s past manufacturing delays and rising competition in x86 CPUs and AI accelerators. The real question is whether you think a buyer today can reasonably assume that regaining process parity will be enough to blunt AMD and Nvidia pressure.
"BEAR Intel encountered significant manufacturing delays in years past, and there is no guarantee that it can execute well in its aggressive aspirations to develop five process nodes in four years. Even if Intel can regain manufacturing parity with TSMC, AMD now sits as a far more credible chip designer in the x86 space for PC and server CPUs."
The price and this Narrative do not agree. → Uncover what this Narrative says Intel is actually worth
Which Company Could Surprise You Next?
What if your next investment idea came before the headlines? Go straight to the companies whose prices and our estimates still disagree. Three places to start, with the names waiting behind the link.
- Company 1 - 34% below our estimate - targets complex aerospace, defense and medical programs as major awards move into production.
- Company 2 - 22% below our estimate - leans on rising robotic surgery adoption and higher acuity procedures to deepen system utilization.
- Company 3 - 28% below our estimate - captures grid modernization and test-equipment demand while integrating a large-scale diagnostics-focused acquisition.
Those are three of them. See every one of the 29 undervalued companies on it →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com